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Abstract
Aim: To explore the M1/M2 status of macrophage polarization from healthy, gingivi-
tis, and periodontitis patient samples.
Materials and methods: Gingival biopsies were collected from 42 individuals (14 
gingivitis, 18 periodontitis, and 10 healthy samples) receiving periodontal therapy. 
Histomorphology analysis was performed with haematoxylin and eosin staining. 
Immunofluorescence was performed using a combination of CD68 (macrophages), 
iNOS (M1), and CD206 (M2) in order to acquire changes in macrophage polarization 
at a single‐cell resolution. Macrophages were quantified under microscopy using nar-
row wavelength filters to detect Alexa 488, Alexa 568, Alexa 633 fluorophores, and 
Hoechst 33342 to identify cellular DNA content.
Results: Gingivitis and periodontitis samples showed higher levels of macrophages 
compared with healthy samples. Unexpectedly, periodontitis samples displayed 
lower levels of macrophages dispersed in the stromal tissues compared with gingivitis 
samples; however, it remained higher than healthy tissues. The polarization of mac-
rophages appears to be reduced in periodontitis and showed similar levels to those 
observed in healthy tissues.
Conclusions: Our study found that gingivitis and periodontitis differ from each other 
by the levels of macrophage infiltrate, but not by changes in macrophage polarization.
K E Y W O R D S
allergy and immunology, gingivitis, immunohistochemistry, immunologic factors, 
inflammation, periodontitis
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1  | INTRODUC TION
Periodontal diseases are infectious and inflammatory conditions 
that disrupt the periodontium homeostasis, collectively affecting 
the gingiva, alveolar bone, periodontal ligament, and cementum. 
Periodontitis is characterized by a spread of inflammatory infil-
trate progressively into the periodontal tissues, resulting in loss 
of attachment and alveolar bone together with the apical migra-
tion of the junctional epithelium (Kinane, Bouchard, & Group E of 
European Workshop on Periodontology, 2008; Page & Schroeder, 
1976). A high prevalence of periodontitis was confirmed from a re-
cent National Health and Nutrition Examination Survey (NHANES) 
study reporting that nearly 50% of the United States population is 
affected (Eke et al., 2015). The more severe form of periodontitis 
affects about 10% of all patients (Kassebaum et al., 2014) suggest-
ing the existence of contributing factors such as gene polymor-
phisms (Divaris et al., 2013) and increased host susceptibility for 
disease progression (Eke et al., 2015, 2016; Loe, Anerud, Boysen, 
& Morrison, 1986).
Over the past decades, different disease progression models 
for periodontitis have been described addressing bacterial bio-
film as the primary aetiology (Jeffcoat & Reddy, 1991; Socransky, 
Haffajee, Goodson, & Lindhe, 1984; Teles et al., 2016). However, 
limited evidence on the transition from established to advanced 
stages of periodontitis is available. Experimental human models 
have provided valuable information on the key role of biofilm and 
patterns of adaptive‐innate immune responses (Loe, Theilade, & 
Jensen, 1965; Seymour, Powell, & Aitken, 1983). Conversely, a 
particular group of individuals does not display signs of progres-
sive attachment and/or bone loss despite the presence of biofilm 
and gingival inflammation (Hugoson, Sjodin, & Norderyd, 2008). 
In other instances, long‐standing gingivitis lesions exhibit differ-
ent cellular composition to periodontitis lesions (Thorbert‐Mros, 
Larsson, & Berglundh, 2015). The hypothesis of immunological 
mechanisms down‐regulating the destructive nature could explain 
why some established lesions might not progress into advanced 
forms.
Several mechanisms may influence disease progression of 
periodontitis like epigenetic deregulation of the periodontium 
homeostasis resulting in dysfunctional host response to local 
microbiota and the development of an endotoxin‐tolerant phe-
notype elicited by chronic exposure of periodontal tissues to 
bacterial endotoxins (Martins et al., 2016; Seeley & Ghosh, 2017; 
Zhang et al., 2013). In fact, activation of the endotoxin tolerance 
mechanism constitutes an emerging area of interest in chronic 
inflammatory diseases and may hold the promise to better under-
stand disease progression of patients at high risk for the develop-
ment of periodontitis.
The proportional distribution of inflammatory cells in peri-
odontitis lesion has been described in reviews on studies reporting 
on histological evaluations of human samples (Berglundh & Donati, 
2005; Berglundh, Zitzmann, & Donati, 2011). Thus, B cells and 
plasma cells together occupy about 60%, T helper and T‐cytotoxic 
cells 17%, while macrophages and neutrophils represent 5%–7% 
of the inflammatory cell population. Similar results were reported 
in recent assessments of human periodontitis lesions (Carcuac & 
Berglundh, 2014; Thorbert‐Mros et al., 2015). Although occurring 
in relatively small proportions; macrophages exhibit essential de-
fence and regulatory functions. The phagocytic abilities of mac-
rophages as resident cells or monocyte‐derived cells recruited 
upon inflammation are key players in the development of acquired 
immunity (Martinez & Gordon, 2014). Macrophages are endowed 
with high cellular plasticity capable of responding to distinct envi-
ronmental signals. Upon activation, macrophages can differentiate 
into M1 (classical) or M2 (alternative) phenotypes, with M1 being 
pro‐inflammatory and involved in bacterial killing and promoting 
inflammation by an increase in production of interleukin‐6 (IL‐6), 
tumour necrosis factor‐alpha (TNF‐α), and inducible nitric oxide 
synthase (iNOS).
In contrast, the M2 phenotype plays a role in the resolution 
of inflammation and tissue repair being characterized by the pro-
duction of IL‐10 and a decreased expression of in IL‐6 (Das et al., 
2015; Garlet & Giannobile, 2018; Yu et al., 2016). Furthermore, 
macrophage polarization to an M2 phenotype has been associ-
ated with the presence of chronic infections (Mills & Ley, 2014). 
Animal models for experimental periodontitis have shown high 
levels of TGF‐β, CD80, and TNF‐α mRNA expression during early 
inflammatory process of ligature‐induced periodontitis (M1), while 
high CD206 expression level was found during tissue healing (M2) 
(Viniegra et al., 2018). Despite the importance of M1/M2 polar-
ization in inflammatory diseases, little is known about the macro-
phage polarization status of periodontitis and gingivitis in humans. 
In this investigation, we explored the macrophage content and 
polarization of periodontitis compared with gingivitis and healthy 
gingiva tissues to better understand macrophage polarization in 
vivo.
Clinical Relevance
Scientific rationale for the study: Oral dysbiosis may lead to 
significant changes in the host immune response. The bal-
ance of M1/M2 signalling could reflect a response to peri-
odontal therapy and host susceptibility for inflammatory 
and immunosuppression events.
Principal findings: Healthy tissues, gingivitis, and periodon-
titis samples were characterized by a mixed population of 
CD68‐positive macrophages presenting M1, M2, and the 
combination/transition of M1 and M2 polarization.
Practical implications: Future development of locally deliv-
ered host‐modulation drugs could target macrophages to 
reverse or enhance immunosuppressive events for treat-
ment and prevention of periodontal diseases.
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2  | MATERIAL S AND METHODS
2.1 | Subject selection
Forty‐two patients (38.08% females and 61.89% males) provided 
a total of 10 healthy, 14 gingivitis, and 18 periodontitis biopsies. 
Overall, the patients’ mean age was 56.75 years (Range: 19–75 years 
old). Six patients (14.28%) reported a history of smoking (>1 year). 
Analysis of the effects of smoking, age, or gender was not accessed 
in this study. Based on the periodontal clinical and radiographic pa-
rameters, demographic data of all included subjects were subdivided 
into three groups according to the previously described disease cat-
egories as depicted in Table 1.
Research subjects were recruited from patients seeking dental 
treatment or receiving active/supportive therapy at the Graduate 
Periodontics Clinic from the University of Michigan School of 
Dentistry (n = 32, 10 healthy, 10 gingivitis, and 12 periodontitis) 
and the Clinic of Periodontics, Public Dental Service, and Clinic 
for undergraduate training, Institute of Odontology, Sahlgrenska 
Academy, University of Gothenburg (n = 10, four gingivitis and six 
periodontitis). The study protocols were reviewed and approved 
by the University of Michigan Health Science Institutional Review 
Board (HUM00097548) and the local Human Review Board at 
University of Gothenburg (Dnr 677‐05) to ensure participants’ rights 
were protected. This study was performed in accordance with the 
Helsinki Declaration of 1964, as revised in 2013.
To be eligible for this study, patients possessing 20 or more 
teeth received a complete oral examination. The inclusion crite-
ria combined periodontal probing depths (PD) (<4 mm for gingi-
vitis and ≥4 mm for periodontitis), clinical attachment level (CAL) 
(<3 mm for gingivitis and ≥3 mm for periodontitis), radiographic 
marginal bone loss (MBL) (≥50% for periodontitis), and bleeding on 
probing (BOP) assessed at six sites per tooth. Gingivitis samples 
were used here as controls for periodontitis; therefore, we paid 
special attention to the selection of the biopsy site. Tissue har-
vesting was exclusively removed from areas presenting no clinical 
history of periodontitis, along radiograph data with lack of bone 
loss. All inclusion criteria were accessed at six sites per tooth for 
gingivitis patients and 4 sites per tooth for periodontitis patients. 
Other measurements included furcation involvement (FI), gingival 
bleeding index (GBI), bleeding with exudate (BE), mobility, fremi-
tus, and zone of keratinized gingiva.
Patients were excluded if they possessed any of the following 
conditions: (a) uncontrolled systemic disease or condition is known 
to alter bone metabolism (e.g. osteoporosis, osteopenia, hyper-
parathyroidism, Paget's disease); (b) pregnancy; (c) history of oral 
cancer, sepsis or adverse outcomes to oral procedures; (d) long‐
term use of antibiotics (>2 weeks in the past 2 months); and (e) pa-
tients taking medications known to modify bone metabolism (e.g. 
bisphosphonates, corticosteroids, hormone replacement therapy), 
past (<1 year) and current smokers. Before enrolment, all subjects 
received information about the study and signed informed con-
sent. Patients requiring at least one surgical procedure within the 
periodontium whereby a gingival biopsy could be harvested were 
identified.
2.2 | Sample collection and processing
Samples were obtained from a single site around common dental and 
periodontal procedures displaying the most evident clinical signs of 
chronic inflammation (deepest PD site, oedema, red/purple‐col-
oured gingiva, and profuse bleeding). Gingivectomies after ortho-
dontic treatment and aesthetic crown lengthening procedures were 
employed for control subjects for aesthetic purposes. Patients af-
fected with gingivitis; clinical crown lengthening was used to reflect 
chronic gingival inflammation for restorative and biologic purposes. 
Ultimately, open flap debridement and/or respective approaches 
were selected for periodontitis‐affected patients. Removal of these 
tissue biopsies did not interfere with regular (internal bevelled) in-
cisions or procedures as presented in the initial treatment plan or 
influence upon the expected clinical outcomes. After collection, 
biopsies were fixed in a 4% formalin solution for 24 hr of fixation, 
dehydrated, and embedded in paraffin. The samples were stored as 
coded specimens not to reveal patient‐related information.
Characteristic (total) Healthy Gingivitis Periodontitis
Inclusion criteria No CAL
PD ≤ 4mm








BOP (GBI ≥ 2)
MBL (≥50%)
Subjects (n = 42) 10 14 18
Males (61.89%) 14.28% 21.42% 26.19%
Females (38.08%) 9.52% 11.90% 16.66%
Past smokers (n = 6) 4.76% 0% 9.52%
Mean age (years) 
(56.75 years old 
[19–75])
49.10 (19–72) 61.50 (39–64) 59.16 (30–75)
Abbreviations: BOP, bleeding on probing; CAL, clinical attachment level; GBI, gingival bleeding 
index; MBL, marginal bone loss; PD, probing depths.
TA B L E  1   Demographic characteristics 
of study participants
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2.3 | Identification of single‐cell macrophage 
polarization using immunofluorescence
Sections of approximately 4 μm in thickness were dewaxed, hydrated, 
and incubated in antigen retrieval solution of 10 mM/L sodium cit-
rate buffer (pH 6). The sections were incubated with 3% bovine 
serum albumin (BSA) in phosphate buffered saline for blocking of 
unspecific binding followed by incubation overnight at 4°C with 
the following primary antibodies (Dilution 1:50): anti‐CD68 (rab-
bit monoclonal antibody; Thermo Scientific), anti‐iNOS (MAB9502; 
R&D System), and anti‐CD206 (goat AF2534; R&D System). The sec-
tions were then incubated with Alexa‐conjugated secondary anti-
bodies: Alexa‐488 anti‐goat (dilution 1:200), Alexa‐568 anti‐rabbit 
(dilution 1:200), and Alexa‐633 anti‐mouse (dilution 1:50) for 1 hr at 
room temperature. The sections were counterstained with Hoechst 
33342 (Sigma‐Aldrich Corp.) to visualize DNA content. The omission 
of the primary antibody was used as negative controls. Images were 
taken using a QImaging® EXi Aqua™ monochrome digital camera at-
tached to a Nikon Eclipse 80i Microscope (Nikon) and visualized with 
QCapturePro software.
2.4 | Quantification of M1 (CD68/iNOS) and M2 
(CD68/CD206) macrophage polarization
Representative areas of each coded sample were photographed (10 
independent fields per sample) including the area of the subsulcular/
junctional epithelium and at the inflamed/infiltrated connective tis-
sue (ICT) (40× objective). Images from each sample were extracted 
using fluorophore channels correspondent to CD68 (total mac-
rophages), CD68/iNOS (M1 polarization), or CD68/CD206 (M2 po-
larization). Only cells presenting double staining for CD68 and iNOS 
or CD68 and CD206 were counted to avoid the quantification of 
non‐macrophages cells expressing iNOS or CD206. All pictures were 
further analysed as monochromatic images using the NIH ImageJ 
software (https ://imagej.nih.gov/ij/) split‐channel mode and further 
quantified using the cell counting plugin app. The results were ex-
pressed as a percentage of positively double‐stained cells among the 
total number of CD68‐positive cells. The samples were evaluated 
by two independent trained and calibrated examiners (LL and CGP).
2.5 | Statistical analysis
Statistical analyses were performed by Student t‐test using GraphPad 
Prism (GraphPad Software). Spearman's rank correlation test was 
used to measure the strength of the correlation between variables 
(CD68/iNOS and CD68/CD206). p value ≤0.05 was considered sta-
tistically significant, and differences were noted by asterisks (*) or p 
values (* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001, and NS 
p > 0.05, not significant). One‐way analysis of variance (ANOVA) fol-
lowed by Tukey's multiple comparison tests was also used for each 
group (healthy, periodontitis, and gingivitis).
3  | RESULTS
3.1 | Single‐cell resolution of macrophage 
polarization in healthy tissues
Here, we explored the macrophage content of the gingival con-
nective tissue localized juxta‐epithelia from healthy samples as a 
baseline for the analysis of tissues from gingivitis or periodontitis 
patients. In order to establish a normal baseline of macrophage con-
tent and subsequently polarization, we evaluated healthy gingival 
tissues for CD68, iNOS (M1), and CD206 (M2) expression levels. 
We found that normal tissues negative for BOP exhibit a density of 
CD68‐positive macrophages at a mean concentration of 5.38 cells 
per microscopic field at a magnification of 200× (Figure 1a). During 
the polarization analysis, macrophages demonstrated co‐expres-
sion of iNOS signifying M1 polarization, with a mean concentration 
of 0.93 cells per field. Healthy tissues also presented macrophages 
undergoing M2 polarization (CD68/CD206‐positive staining) at sig-
nificantly higher levels (mean of 3.4 cells/field) when compared with 
macrophages under M1 polarization (Figure 1a, p ≤ 0.0001). Such 
differences became more evident when gingivitis and periodontitis 
samples were baseline corrected versus healthy tissues. Under these 
F I G U R E  1   Macrophage polarization profile of healthy gingival 
tissues. (a) Graphic display total number of macrophages positive 
for CD68, CD206, and iNOS observed per histological field. Note 
statistically relevant accumulation of macrophages undergoing M2 
compared with M1 polarization (****p < 0.001, SE of difference 
0.3375). (b) Graphical representation of M1 and M2 polarization 
adjusted for the total number of CD68‐positive cells (macrophages) 
displayed as a percentage of total cells. Note higher levels of M2 
polarization in healthy tissues compared with M1 polarization
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circumstances, macrophages undergoing M1 and M2 polarization 
represented a mean of 22.14% and 72.24% of the total number of 
tissue macrophages, respectively (Figure 1b).
3.2 | Gingivitis contains a higher 
number of macrophages when compared with 
periodontitis tissues
Similar to normal healthy tissues, gingivitis and periodonti-
tis tissues are characterized by the presence of CD68‐positive 
macrophages expressing iNOS or CD206 (Figure 2a‐d), and in 
some instances, the co‐expression of all three markers was ob-
served (Figure 2b, box# 4). Such diversity of the expression pat-
tern of macrophages is well observed in Figure 2b,d that illustrates 
macrophages exclusively expressing the surface marker CD68 
and thereby demonstrating M0 polarization (Figure 2b,d, box #1), 
the presence of M1 polarization (Figure 2b,d, box #2), the pres-
ence of M2 polarization (Figure 2b,d, box #3), and the presence of 
macrophages co‐expressing markers for M1 and M2 polarization 
shown here exclusively in the gingivitis samples (Figure 2b box #4). 
F I G U R E  2   M1 and M2 macrophage polarization in gingivitis and periodontitis lesions. (a to d). Representative tissue samples from 
gingivitis and periodontitis presenting single‐colour staining for CD68 (red), iNOS (cyan), CD206 (green) and Hoechst (blue), and merge 
channels. Dashed line delineates epithelial from stromal tissues. Boxed numbers of merged staining depict all observed composition of 
markers including the presence of exclusive staining for CD68‐positive cells without polarization (1), the presence of M1 polarization 
(CD68/iNOS) (2), the presence of M2 polarization (CD68/CD206) (3), and macrophages presenting a combination of all markers (CD68/
iNOS/CD206) (4). (e and f). Heat map representing all observed histological fields from gingivitis (n = 132) and periodontitis (n = 168) fields 
depicting the observed histological polarization pattern. Note prevalence of macrophages undergoing M2 polarization. Colorimetric scale 
bar from 0 to 40 cells per field
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F I G U R E  3   Overall polarization of macrophages from gingivitis and periodontitis samples. (a and b). Quantification of total number of 
macrophages from gingivitis and periodontitis samples presenting exclusive staining for CD68 (red), or double staining for CD68 and iNOS 
(blue), or CD68 and CD206 (green) per field. Note reduced levels of M1 and M2 polarization along with low levels of total macrophages 
in periodontitis disease tissues compared with gingivitis. (c and d) Expression of the baseline corrected percentage of total number of 
macrophages presenting M1 and M2 polarization from gingivitis and periodontitis samples. Macrophages found in gingivitis (mean of 
45.84%, SEM 2.19) and periodontitis (mean of 48.34%, SEM 1.68) tissues show higher numbers of M2 polarization. (e) Representation of 
CD68+ macrophage distribution presenting M1 polarization (iNOS) (18.24% for gingivitis and 20.02% for periodontitis), and M2 polarization 
(CD206) (45.84% for gingivitis and 48% for periodontitis), along with macrophage cells expressing concomitant M1 and M2 polarization 
(16.01% for gingivitis and 14.87% for periodontitis)
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Overall, tissue samples from gingivitis and periodontitis showed 
high levels of M2 polarization as represented by the heat map dis-
tribution containing all quantified histological fields per condition 
(Figure 2e,f).
Interestingly, however, gingivitis tissues differ from periodontitis 
concerning the total number of macrophages distributed within the 
connective tissues. Gingivitis tissues showed nearly doubled num-
ber of macrophages presented per field over periodontitis samples 
F I G U R E  4   Comparative expression of M1 and M2 polarization among healthy and gingivitis and periodontitis tissues. (a) Heat map 
representation of all observed histological fields from healthy (n = 128), gingivitis (n = 132), and periodontitis (n = 168) samples depicting the 
observed histological polarization pattern. Note prevalence of macrophages undergoing M2 polarization for all groups. Colorimetric scale bar 
from 0 to 40 cells per field. (b) Dispersion graphic of macrophage polarization from healthy, gingivitis, and periodontitis samples. (c) Macrophage 
density comparison observed in healthy, gingivitis, and periodontitis groups demonstrating high levels of macrophage accumulation in gingivitis 
samples compared with healthy and periodontitis (****p < 0.0001). Note also higher levels of macrophages in periodontitis samples when 
compared with healthy subjects (**p < 0.01). (d) Dispersion graphic depicting enhanced M1 polarization in gingivitis samples compared with 
healthy and periodontitis tissues (****p < 0.0001), while periodontitis samples do not present statistical differences with healthy group (NS 
p > 0.05). (e) M2 polarization of macrophages is observed in gingivitis samples compared with healthy and periodontitis samples (****p < 0.0001). 
Note that macrophage levels in periodontitis samples do not present statistical differences when compared to healthy tissues (NS p > 0.05)
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(Figure 3a,b, mean of 15.12 cells and 8.04 cells, respectively, red 
circles). Furthermore, gingivitis tissues showed significantly higher 
number of M2 polarization compared with periodontitis (mean of 
7.6 cells/field for gingivitis vs. 3.8 cells/field for periodontitis‐green 
squares), while little difference was observed in M1 polarized cells 
(mean of 2.64 cells/field for gingivitis vs. 1.52 cells/field for peri-
odontitis‐blue triangles) (Figure 3a,b). Most interestingly is that upon 
baseline correction for a total number of macrophages, the ratio of 
M1 and M2 polarization among gingivitis and periodontitis samples 
is maintained. In this way, M2 polarization observed in gingivitis 
samples represents 45% of all detected CD68‐positive cells, while 
M1 polarization corresponds to 18% of all macrophages (Figure 3c). 
Similarly, periodontitis macrophages present 48% of macrophages 
undergoing M2 polarization and 20% of all macrophages undergo-
ing M1 polarization (Figure 3d). Like M1 or M2 polarization, we also 
found macrophages presenting a transition between M1 and M2 po-
larization identified by the co‐labelling of CD68, iNOS, and CD206. 
These macrophages are relatively common within soft tissues of 
gingivitis and periodontitis representing 16% of all stained macro-
phages in gingivitis and 14.8% in periodontitis samples (Figure 3e).
3.3 | The polarization of macrophages in 
periodontitis share similarities with healthy tissues
The screening of all histological fields from health, gingivitis, and 
periodontitis patients revealed a common trend on M2 macrophage 
polarization (Figure 4a,b). Immunofluorescence analysis also re-
vealed that gingivitis tissues presented the highest total numbers of 
macrophages as well as highest M1 and M2 polarization (Figure 4b). 
In fact, it became very evident that gingivitis samples showed higher 
loading levels of macrophages compared with healthy or periodonti-
tis tissues (Figure 4c, p < 0.0001). Although displaying lower numbers 
of macrophages, periodontitis lesions present overall higher counts 
of macrophages compared with healthy tissues (Figure4c, p < 0.01). 
From an M1 polarization perspective, gingivitis tissues demonstrated 
significantly greater polarized macrophages than periodontitis 
(p < 0.001) or healthy (p < 0.0001) samples (Figure 4d). Interestingly, 
there were no statistical differences between healthy tissues and 
periodontitis tissues related to M1 polarization (p > 0.05). M2 polari-
zation followed a similar trend in which gingivitis samples were once 
again highly identified in the soft tissues compared with healthy or 
periodontitis samples (Figure 4e, p < 0.0001). Nonetheless, there 
were no statistical differences between the M2 polarization of peri-
odontitis or healthy tissues (p > 0.05).
All in all, our study found that gingivitis and periodontitis differ 
from each other by the levels of macrophage infiltrate, but not by 
changes in macrophage polarization.
4  | DISCUSSION
Based on the concept of host‐modulation, macrophages play im-
portant roles as mediators and effector in the immune response 
mediated by Th1 and Th2 cells (Mills, Kincaid, Alt, Heilman, & Hill, 
2000). The role of M1/M2 macrophage polarization in the patho-
genesis of periodontal disease has proven difficult to define. Much 
of the complications of the field rely on the individual analysis of M1 
or M2 polarization of macrophages using immunohistochemistry 
techniques, while only a few studies explore the presence of both 
phenotypes, especially at a single‐cell resolution. For example, M1 
focused studies have noted an M1‐polarization phenotype in peri-
odontitis (Gheren, Cortelli, Rodrigues, Holzhausen, & Saad, 2008; 
Gorska et al., 2003; Gullu, Ozmeric, Tokman, Elgun, & Balos, 2005; 
Holden et al., 2014; Hussain, McKay, Gonzales‐Marin, & Allaker, 
2016; Lam et al., 2014; Lappin, Kjeldsen, Sander, & Kinane, 2000; 
Navarrete et al., 2014; Ozmeric, Elgun, & Uraz, 2000), while other 
studies have shown enhanced accumulation of an M2 phenotype 
(Gheren et al., 2008; Navarrete et al., 2014). Adding to the M1/M2 
paradigm complexity, a reduction in M2 polarization found in perio-
dontitis lesions has also been demonstrated (Gullu et al., 2005; Lam 
et al., 2014).
To address this shortcoming in the literature, we designed a 
well‐controlled experiment using a representative cohort of patients 
ranging from 19 to 75 years old presenting no clinical history of un-
controlled systemic disease or use of drugs that could have an im-
pact over the bone metabolism. We also decided to carefully exclude 
pregnant as well as patients with a history of oral cancer, sepsis, use 
of antibiotics, and smokers. As our study design aims to explore a 
more accurate picture from a pathogenesis standpoint and minimize 
potential environmental factors (e.g. smoking), we focused on a co-
hort of patients presenting stable periodontal disease progression.
Some other methodological improvements were included in 
this study aiming at reducing the bias of using a single antibody per 
histological sections. By implementing four different fluorescent 
channels, we gain single‐cell resolution of macrophages undergoing 
polarization, along with reduced bias in quantifying non‐macrophage 
cells expressing M1 and M2 polarization markers and gaining in the 
ability to identify macrophages undergoing an M1‐M2 transition. 
At last, we decided to evaluate the global macrophage polarization 
throughout the gingival tissue samples by accounting for the total 
number of macrophages located at the ICT and distributed at the 
subjacent mucosa.
Our strategy demonstrated that macrophages are more fre-
quently found in gingivitis samples compared with periodontitis. 
Furthermore, the ratio of macrophages under M1 or M2 cellular 
polarization followed similar patterns of displaying larger numbers 
in gingivitis compared with periodontitis. From a polarization per-
spective, macrophages were often observed in M2 polarization for 
both conditions, gingivitis, and periodontitis. Much of these findings 
suggest an overall presence of a chronic phase of inflammation in 
both inflammatory conditions compared with an acute process rep-
resented by an M1 polarization. This observation may elute to the 
observed overall reduction in the total number of macrophages 
observed in periodontitis samples and suggests a reset of macro-
phages influx to levels observed in normal tissues. Down‐regulation 
of macrophage influx may, to some degree, be a weak level of local 
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immunosuppression at the chronic inflammatory anatomical site in 
an attempt to mitigate tissue destruction. Although unexpected, our 
findings align with the observations from Chapple and colleagues 
that observed an apparent failure of recruitment and activation 
of macrophages in destructive periodontitis (Chapple, Srivastava, 
& Hunter, 1998). Another study from Lins and collaborators also 
demonstrated the presence of a higher density of macrophages in 
gingivitis samples compared with chronic periodontitis (Lins et al., 
2008). Conversely, Thorbert‐Mros et al. (2015) showed evidence 
on the accumulation of macrophages within the composition of the 
inflammatory infiltrate from severe generalized periodontitis com-
pared with long‐standing gingivitis. All studies present robust meth-
odologies but differ on the approach and patient cohort composition.
In the context of cellular phenotype, the polarization of macro-
phages might be part of both inductive and resolving mechanisms 
of tissue inflammation (Das et al., 2015; Viniegra et al., 2018). Yu 
and co‐workers described a phenotypic switch from M2 to M1 from 
bone marrow‐derived macrophages after P. gingivalis lipopolysac-
charide (LPS) stimulation in a ligature‐induced periodontitis murine 
model (Yu et al., 2016). We also observed the presence of a cohort 
of macrophages presenting a combined polarization phenotype si-
multaneously expressing M1 and M2 markers. Such finding was con-
sistently observed in gingivitis (16.01%) and periodontitis (14.87%) 
samples, suggesting greater plasticity of macrophages capable of 
transition between M1 and M2 polarization.
Macrophage polarization‐modulating agents might be consid-
ered in the future as immune regulation drugs for the prevention, 
treatment, and reduction in patient susceptibility for periodontal dis-
eases (Di Paola et al., 2006; Hassumi et al., 2009; Sima & Glogauer, 
2013). Recently, rosiglitazone induction of pro‐resolving macro-
phages has shown to reduce bone resorption and increase bone for-
mation during healing in experimental ligature‐induced periodontitis 
(Viniegra et al., 2018). Advancements in immunology and a complete 
understanding of the role of macrophages in the transition of estab-
lished to advanced stages of periodontal disease could open new 
fields for the development of diagnostics and therapeutic tools in 
periodontics.
In summary, our ability to identify the polarization of mac-
rophages at a single‐cell resolution provides a unique landscape 
of healthy tissues, gingivitis, and periodontitis. Our study found 
that gingivitis and periodontitis differ from each other by the lev-
els of macrophage infiltrate, but not by changes in macrophage 
polarization.
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